Other options
view Contact Information
Contact Information for MLN0128 and Alisertib for Metastatic Triple-Negative Breast (and Other Advanced) Cancers
The sites for this trial are listed below.
If you speak with a site, please mention that you were referred by BreastCancerTrials.org
University of Colorado Cancer Center, Aurora, CO, 80045
Principal Investigator: | Jennifer Diamond, MD |
Contact person: | Matthew Lee |
Phone: | 303-848-0630 |
Email: | matthew.lee@ucdenver.edu |